These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 10364074

  • 1. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
    Lee C, Sigari F, Segrado T, Hörkkö S, Hama S, Subbaiah PV, Miwa M, Navab M, Witztum JL, Reaven PD.
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074
    [Abstract] [Full Text] [Related]

  • 2. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
    Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA.
    J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
    [Abstract] [Full Text] [Related]

  • 3. Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL.
    Sigari F, Lee C, Witztum JL, Reaven PD.
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3639-45. PubMed ID: 9437216
    [Abstract] [Full Text] [Related]

  • 4. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Noto H, Hara M, Karasawa K, Iso-O N, Satoh H, Togo M, Hashimoto Y, Yamada Y, Kosaka T, Kawamura M, Kimura S, Tsukamoto K.
    Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):829-35. PubMed ID: 12649088
    [Abstract] [Full Text] [Related]

  • 5. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR, La Belle M, Forte TM, Krauss RM, Takanami Y, Tribble DL.
    Biochim Biophys Acta; 1999 Jan 29; 1437(1):23-36. PubMed ID: 9931415
    [Abstract] [Full Text] [Related]

  • 6. LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed to oxidative stress.
    Tsimikas S, Philis-Tsimikas A, Alexopoulos S, Sigari F, Lee C, Reaven PD.
    Arterioscler Thromb Vasc Biol; 1999 Jan 29; 19(1):122-30. PubMed ID: 9888874
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
    Quarck R, De Geest B, Stengel D, Mertens A, Lox M, Theilmeier G, Michiels C, Raes M, Bult H, Collen D, Van Veldhoven P, Ninio E, Holvoet P.
    Circulation; 2001 May 22; 103(20):2495-500. PubMed ID: 11369691
    [Abstract] [Full Text] [Related]

  • 8. Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.
    Eisaf M, Tselepis AD.
    Biochem Pharmacol; 2003 Dec 01; 66(11):2069-73. PubMed ID: 14609731
    [Abstract] [Full Text] [Related]

  • 9. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD.
    Eur J Clin Invest; 1997 Jul 01; 27(7):595-602. PubMed ID: 9263748
    [Abstract] [Full Text] [Related]

  • 10. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
    Tselepis AD, John Chapman M.
    Atheroscler Suppl; 2002 Dec 01; 3(4):57-68. PubMed ID: 12573364
    [Abstract] [Full Text] [Related]

  • 11. Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration.
    Zhang B, Fan P, Shimoji E, Itabe H, Miura S, Uehara Y, Matsunaga A, Saku K.
    Atherosclerosis; 2006 Jun 01; 186(2):291-301. PubMed ID: 16154574
    [Abstract] [Full Text] [Related]

  • 12. IDL, VLDL, chylomicrons and atherosclerosis.
    Nordestgaard BG, Tybjaerg-Hansen A.
    Eur J Epidemiol; 1992 May 01; 8 Suppl 1():92-8. PubMed ID: 1505659
    [Abstract] [Full Text] [Related]

  • 13. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats.
    Wójcicka G, Zaręba M, Warpas A, Jamroz-Wiśniewska A, Rusek M, Czechowska G, Bełtowski J.
    Eur J Pharmacol; 2019 May 05; 850():180-189. PubMed ID: 30768981
    [Abstract] [Full Text] [Related]

  • 14. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA, Elisaf MC, Goudevenos J, Siamopoulos KC, Sideris D, Tselepis AD.
    Atherosclerosis; 1996 Aug 23; 125(1):121-34. PubMed ID: 8831934
    [Abstract] [Full Text] [Related]

  • 15. HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice.
    Theilmeier G, De Geest B, Van Veldhoven PP, Stengel D, Michiels C, Lox M, Landeloos M, Chapman MJ, Ninio E, Collen D, Himpens B, Holvoet P.
    FASEB J; 2000 Oct 23; 14(13):2032-9. PubMed ID: 11023987
    [Abstract] [Full Text] [Related]

  • 16. Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.
    Tsimihodimos V, Kakafika A, Tambaki AP, Bairaktari E, Chapman MJ, Elisaf M, Tselepis AD.
    J Lipid Res; 2003 May 23; 44(5):927-34. PubMed ID: 12611907
    [Abstract] [Full Text] [Related]

  • 17. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.
    Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M.
    J Lipid Res; 2002 Feb 23; 43(2):256-63. PubMed ID: 11861667
    [Abstract] [Full Text] [Related]

  • 18. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
    Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM.
    J Lipid Res; 2000 Sep 23; 41(9):1495-508. PubMed ID: 10974057
    [Abstract] [Full Text] [Related]

  • 19. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
    Dentan C, Lesnik P, Chapman MJ, Ninio E.
    Arterioscler Thromb; 1994 Mar 23; 14(3):353-60. PubMed ID: 8123638
    [Abstract] [Full Text] [Related]

  • 20. Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction.
    Benítez S, Sánchez-Quesada JL, Ribas V, Jorba O, Blanco-Vaca F, González-Sastre F, Ordóñez-Llanos J.
    Circulation; 2003 Jul 08; 108(1):92-6. PubMed ID: 12821559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.